Nicox S. A announced that Dr. Tomas Navratil, has been promoted to Executive Vice President, Head of R&D of the Nicox Group as of January 1, 2020. In this expanded role, Dr. Navratil will be responsible for all research, non-clinical and clinical development, CMC and regulatory affairs activities for Nicox and general management of Nicox U.S. operations in Durham, North Carolina.